fludarabine has been researched along with Aspergillosis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, BL; Li, J; Li, SX; Liu, Y; Wang, HT; Wang, TM; Zhai, B; Zhu, HL | 1 |
| Gil, L; Komarnicki, M; Kozlowska-Skrzypczak, M; Mol, A; Poplawski, D; Styczynski, J | 1 |
| Asano, S; Iseki, T; Konuma, T; Nakaoka, T; Ooi, J; Takahashi, S; Takasugi, K; Tojo, A; Tomonari, A; Tsukada, N; Uchiyama, M | 1 |
| Abidi, MH; Alangaden, G; Chandrasekar, PH; Heilbrun, LK; Klein, JL; Mellon-Reppen, S; Narreddy, S; Peres, E; Smith, D | 1 |
| Huisman, CA; Laros-van Gorkom, BA; Schipperus, MR; Wijermans, PW | 1 |
| Besser, M; Cargill, JS; Craig, JI; Crawley, C; Enoch, DA; Follows, G; Gudgin, E; Ludlam, HA; Marcus, RE; Min, SY; Sartori, P; Todd, T | 1 |
| Fukuda, T; Heike, Y; Kato, R; Kim, S; Koido, K; Maruyama, D; Mori, S; Takaue, Y; Tanosaki, R; Teshima, T; Tobinai, K; Usui, E; Yamasaki, S | 1 |
| Boscagli, A; Dujardin, P; Gary-Toussain, M; Peyrade, F; Roa, M; Taillan, B | 1 |
| Nagler, A; Or, R; Panigrahi, S; Shapira, MY; Slavin, S; Wolf, DG | 1 |
1 trial(s) available for fludarabine and Aspergillosis
| Article | Year |
|---|---|
Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Sepsis; Stomatitis; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2006 |
8 other study(ies) available for fludarabine and Aspergillosis
| Article | Year |
|---|---|
[Elderly chronic lymphocytic leukemia combined with invasive aspergillosis infection in one case].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Flow Cytometry; Humans; In Situ Hybridization, Fluorescence; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Remission Induction; Rituximab; Vidarabine | 2015 |
Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Carmustine; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphoproliferative Disorders; Male; Melphalan; Middle Aged; Neutropenia; Prospective Studies; Risk Factors; Rituximab; Vidarabine; Young Adult | 2009 |
Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients.
Topics: Academies and Institutes; Antineoplastic Agents; Aspergillosis; Cyclophosphamide; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Michigan; Middle Aged; Myeloablative Agonists; Neoplasms; Opportunistic Infections; Retrospective Studies; Review Literature as Topic; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2007 |
Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Aspergillosis; CD52 Antigen; Drug Evaluation; Drug Resistance, Neoplasm; Glycoproteins; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Medical Records; Netherlands; Opportunistic Infections; Pneumonia, Pneumocystis; Remission Induction; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome; Vidarabine | 2007 |
Invasive fungal sinusitis in patients treated with fludarabine.
Topics: Adolescent; Adult; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Child; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mucormycosis; Rhizopus; Sinusitis; Vidarabine | 2008 |
Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens.
Topics: Adolescent; Adult; Aged; Aspergillosis; Bacteremia; Busulfan; Catheterization, Central Venous; Chronic Disease; Communicable Diseases; Cyclophosphamide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pneumonia, Bacterial; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2008 |
[A nidulans bronchial aspergillosis after treatment of low-grade lymphoma with fludarabine].
Topics: Antineoplastic Agents; Aspergillosis; Bronchial Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Vidarabine | 1997 |
Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation.
Topics: Adult; Arthritis; Aspergillosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Knee Joint; Male; Middle Aged; Vidarabine | 2001 |